JOHNSON & JOHNSON

JNJ · Mega cap · 2 articles

Financial highlights

Metric	FY 12/28/25	FY 12/29/24	FY 12/31/23	FY 01/01/23	FY 01/02/22
Income Statement
Revenue	$94.2B	$88.8B	$85.2B	$80.0B	$78.7B
Cost of revenue	$30.3B	$27.5B	$26.6B	$24.6B	$23.4B
Gross profit	$63.9B	$61.4B	$58.6B	$55.4B	$55.3B
Selling, general & administrative	$23.7B	$22.9B	$21.5B	$20.2B	$20.1B
Research and development	$109.0M	$1.8B	$483.0M	$0	$0
Interest expense	$971.0M	$755.0M	$772.0M	$276.0M	$183.0M
Pretax income	$32.6B	$16.7B	$15.1B	$19.4B	$19.2B
Income tax expense	$5.8B	$2.6B	$1.7B	$3.0B	$1.4B
Net income	$26.8B	$14.1B	$35.2B	$17.9B	$20.9B
Balance Sheet
Cash and equivalents	$19.7B	$24.1B	$21.9B	$12.9B	$14.5B
Current assets	$55.6B	$55.9B	$53.5B	$55.3B	$61.0B
Total assets	$199.2B	$180.1B	$167.6B	$187.4B	$182.0B
Current liabilities	$54.1B	$50.3B	$46.3B	$55.8B	$45.2B
Total liabilities	$117.7B	$108.6B	$98.8B	$110.6B	$108.0B
Stockholders' equity	$81.5B	$71.5B	$68.8B	$76.8B	$74.0B
Cash Flow Statement
Cash from operations	$24.5B	$24.3B	$22.8B	$21.2B	$23.4B
Depreciation and amortization	$7.5B	$7.3B	$7.5B	$7.0B	$7.4B
Stock-based compensation	$1.4B	$1.2B	$1.2B	$1.1B	$1.1B
Capital expenditure	$4.8B	$4.4B	$4.5B	$4.0B	$3.7B
Free cash flow	$19.7B	$19.8B	$18.2B	$17.2B	$19.8B
Dividends paid	$12.4B	$11.8B	$11.8B	$11.7B	$11.0B
Share repurchases	$6.0B	$2.4B	$5.1B	$6.0B	$3.5B
Impairments	$204.0M	$405.0M	$1.3B	$1.2B	$989.0M

Shares outstanding 2.4B · Free float 99.8%

Annual filing data through FY ended December 28, 2025; float as of July 8, 2026.